(Wilding et al., NEJM, 2021 PubMed: 33567185) STEP 2 Trial (2021) In patients with both obesity and type 2 diabetes, semaglutide 2.4 mg produced mean weight loss of 9.6% versus 3.4% with placebo at 68 weeks
At Body Sculpt Skin & Laser, weve helped countless clients restore volume and firmness to their skin using RF, RF Microneedling, and Ultherapy
Finally, a post-mortem analysis of human brain samples showed increased hippocampal expression of genes encoding for GLP-1R in individuals with severe alcohol-use disorder compared with controls 71
For more on the science of metabolic hormones, check UC Davis white paper
Zepbound, Oral Wegovy, and Foundayo are all FDA-approved, and many insurance plans include coverage for them when prescribed for weight management or a related health condition
Clinically IGF-1 is used to treat growth hormone deficiency, improves muscle strength and mobility especially in older women